These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 2531613

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Affinity chromatography of the D1 dopamine receptor from rat corpus striatum.
    Gingrich JA, Amlaiky N, Senogles SE, Chang WK, McQuade RD, Berger JG, Caron MG.
    Biochemistry; 1988 May 31; 27(11):3907-12. PubMed ID: 3415962
    [Abstract] [Full Text] [Related]

  • 24. Improvement in conditions for solubilisation and characterisation of brain D2 dopamine receptors using various detergents.
    Wheatley M, Hall JM, Frankham PA, Strange PG.
    J Neurochem; 1984 Oct 31; 43(4):926-34. PubMed ID: 6470714
    [Abstract] [Full Text] [Related]

  • 25. Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines.
    Monsma FJ, Brassard DL, Sibley DR.
    Brain Res; 1989 Jul 17; 492(1-2):314-24. PubMed ID: 2665904
    [Abstract] [Full Text] [Related]

  • 26. Antipeptide antibodies localize N-(4-azido-3-[125I] iodophenethyl)spiperone binding to the carboxyl-terminal portion of the D2 dopamine receptor.
    David C, Fuchs S.
    Mol Pharmacol; 1991 Nov 17; 40(5):712-6. PubMed ID: 1834930
    [Abstract] [Full Text] [Related]

  • 27. Dopamine agonist high-affinity state in solubilized D2 receptors in striatum, but not in anterior pituitary.
    Dumbrille-Ross A, Seeman P.
    Biochem Pharmacol; 1987 Jul 01; 36(13):2095-9. PubMed ID: 2955789
    [Abstract] [Full Text] [Related]

  • 28. Identification of the ligand-binding subunit of the human 5-hydroxytryptamine1A receptor with N-(p-azido-m-[125I] iodophenethyl)spiperone, a high affinity radioiodinated photoaffinity probe.
    Raymond JR, Fargin A, Lohse MJ, Regan JW, Senogles SE, Lefkowitz RJ, Caron MG.
    Mol Pharmacol; 1989 Jul 01; 36(1):15-21. PubMed ID: 2526292
    [Abstract] [Full Text] [Related]

  • 29. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL, Largent BL, Snyder SH.
    Life Sci; 1984 Nov 05; 35(19):1981-8. PubMed ID: 6149442
    [Abstract] [Full Text] [Related]

  • 30. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
    Niznik HB, Guan JH, Neumeyer JL, Seeman P.
    Mol Pharmacol; 1985 Feb 05; 27(2):193-9. PubMed ID: 3969068
    [Abstract] [Full Text] [Related]

  • 31. Characterization of novel fluorescent ligands with high affinity for D1 and D2 dopaminergic receptors.
    Monsma FJ, Barton AC, Kang HC, Brassard DL, Haugland RP, Sibley DR.
    J Neurochem; 1989 May 05; 52(5):1641-4. PubMed ID: 2523470
    [Abstract] [Full Text] [Related]

  • 32. A novel affinity purification of D-1 dopamine receptors from rat striatum.
    Sidhu A.
    J Biol Chem; 1990 Jun 15; 265(17):10065-72. PubMed ID: 2141020
    [Abstract] [Full Text] [Related]

  • 33. Partial purification of dopamine D2 receptors using lectin affinity columns.
    Abbott WM, Strange PG.
    Biosci Rep; 1985 Apr 15; 5(4):303-8. PubMed ID: 3161556
    [Abstract] [Full Text] [Related]

  • 34. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 15; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 35. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system.
    Richfield EK, Penney JB, Young AB.
    Neuroscience; 1989 Jan 15; 30(3):767-77. PubMed ID: 2528080
    [Abstract] [Full Text] [Related]

  • 36. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB, Grigoriadis DE, Pri-Bar I, Buchman O, Seeman P.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun 15; 329(4):333-43. PubMed ID: 2863760
    [Abstract] [Full Text] [Related]

  • 37. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
    Kessler RM, Ansari MS, Schmidt DE, de Paulis T, Clanton JA, Innis R, al-Tikriti M, Manning RG, Gillespie D.
    Life Sci; 1991 Jun 15; 49(8):617-28. PubMed ID: 1830917
    [Abstract] [Full Text] [Related]

  • 38. Dopamine D2 receptor binding subunits of Mr congruent to 140,000 and 94,000 in brain: deglycosylation yields a common unit of Mr congruent to 44,000.
    Jarvie KR, Niznik HB, Seeman P.
    Mol Pharmacol; 1988 Aug 15; 34(2):91-7. PubMed ID: 2970586
    [Abstract] [Full Text] [Related]

  • 39. Dopamine D2 receptor binding in adrenal medulla: characterization using [3H]spiperone.
    Quik M, Bergeron L, Mount H, Philie J.
    Biochem Pharmacol; 1987 Nov 01; 36(21):3707-13. PubMed ID: 2960326
    [Abstract] [Full Text] [Related]

  • 40. [3H]Pramipexole: a selective radioligand for the high affinity dopamine D2 receptor in bovine striatal membranes.
    Ohnmacht U, Tränkle C, Mohr K, Gmeiner P.
    Pharmazie; 1999 Apr 01; 54(4):294-7. PubMed ID: 10234741
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.